Cedarburg Hauser Pharmaceuticals Leadership Team
R. Anthony Laughrey -- Chief Executive Officer
Charles Boland, MBA -- Executive Vice President
Dan W. Childers, RAC, MT -- Vice President, Corporate Quality and Regulatory Compliance
Richard Pariza, Ph.D. -- Chief Science Officer
Paul Zizelman, MS -- Director of Scientific Operations
Barbara England, Ph.D. -- Vice President of Quality Systems
Mark Millar -- Director, Project Management and Resource Coordination
R. Anthony Laughrey
Chief Executive Officer
Tony Laughrey is an accomplished C-Level executive with extensive management, operational, and financial experience. His expertise is in turnaround and revitalization of companies in diverse industries worldwide from bio-pharmaceutical, biotech and life sciences companies, to equipment manufacturing and other low tech industries. He has more than 20 years of success in the value creation process for public and private companies, and has successfully provided turnaround management and leadership to more than 30 portfolio companies.
Cedarburg Pharmaceuticals’ fortunes have dramatically changed for the better since March 2007. As President and CEO, Mr. Laughrey has redirected the market focus to that of a Contract Development and Manufacturing Organization (CDMO). Cedarburg provides outsourced services to the biotech and pharma industry with chemistry-based offerings from early synthesis and process scale-up through Active Pharmaceutical Ingredient (API) manufacturing in a cGMP environment.
Previously, as organizer, President and CEO of KBI BioPharma, Inc. in Durham NC, an offshoot of Kinetics BioSystems Inc, Mr. Laughrey envisioned and successfully built a revenue-generating biopharmaceutical contract services organization from an initial non-existent cash situation, securing a niche in the $2.5 billion market for biopharmaceutical development outsourcing and opening a pipeline to the emerging global bio-generic markets.
In his earlier career, Mr. Laughrey earned a record of success in providing entrepreneurial solutions and strategic direction to organizations experiencing rapid growth or change. His reputation as a “Rainmaker” has been aptly earned, as Mr. Laughrey has shown innovation and determination in all of his endeavors – forming several high tech companies, securing debt and private equity, leading an international chemical manufacturer through an IPO, and holding numerous Board Director positions leading organizations to achieve competitive success and growth. Mr. Laughrey holds a Bachelor of Science Degree in Chemistry from LeMoyne College. He was Chairman of the Board of Directors for Cell Products, and has served on the boards of several companies, including KBI BioPharma, Inc., Admetric BioChem, Inc., and LCI Management.
Back to Top
Charles Boland
Executive Vice President
Chuck Boland directs the sales, marketing and strategic planning activities at Cedarburg. He has an BS degree from the Illinois Institute of Technology and an MBA from the University of Chicago and more than thirty years experience in sales, marketing and strategic planning at several pharmaceutical and fine chemical companies, including Lonza, Hoffmann-LaRoche and Amoco BioProducts Corporation. He is a co-founder of Cedarburg Pharmaceuticals, Inc. and is Secretary of the corporation.
Back to Top
Dan Childers
Vice President, Quality Assurance & Regulatory Compliance
Dan Childers directs the Quality Assurance, Quality Control and Regulatory Compliance activities at both the Wisconsin and Colorado sites. He has a B.S. degree in Medical Technology with focused emphasis on microbiology and certification in nuclear medicine. Dan has managed activities for the assurance of product quality in the production of medical products including devices, biologics and pharmaceuticals for over 30 years. During his career he has worked for companies such as Nuclear Medical Laboratories, Organon Teknika, Amgen, BioStar and Hauser Pharmaceutical Services. Dan is Regulatory Affairs Certified through the Regulatory Affairs Professional Society.
Back to Top
Richard Pariza, Ph.D.
Chief Science Officer
Richard Pariza received his Ph.D. degree in Organic Chemistry from Purdue University. He has more than 30 years of leadership on major projects in the pharmaceutical industry. His experience includes positions with Abbott Laboratories, OncQuest, Inc., Protarga, Inc., and Natural Pharmaceuticals. Richard has international recognition as a scientist as well as a scientific manager and leader: Chairman of the prestigious IUPAC Symposium; served on/chaired national ACS committees; frequently invited to chair sessions and lead discussions at international scientific conferences. Former founding editor and now member of the Editorial Board of Organic Process Research & Development, a Research Journal co-sponsored by the American Chemical Society and Royal Society of Chemistry (UK).
Back to Top
Paul Zizelman, MS
Director, Scientific Operations
Paul Zizelman received his BS in Chemistry from Central Michigan University and worked as a graduate research intern at Dow Chemical Co. before starting his Doctoral studies at Indiana University in Bloomington, Indiana. He studied metal mediated organic synthesis under the direction of Professor Jeffrey Mark Stryker. Following graduate school, Paul accepted a position with Aldrich Chemical Company where he became the supervisor of R&D and Glassware production. Capitalizing on ten years in the custom-manufacturing arena, he joined Cedarburg Pharmaceuticals in 1998.
Back to Top
Barbara England, Ph.D.
Vice President, Quality Systems
Barbara England received her Ph.D. in Biochemistry from the University of Chicago where she generated and published structure/function data on the major human Red Blood Cell membrane protein in support of it as the purported anion transport protein. She performed kinetic studies on alpha and beta amylase enzymes for her Iowa State University MS thesis. Barbara has more than 20 years of leadership in the medical device industry. Her experience includes Research and Development, Technical Support and Validation Quality positions with Baxter and Abbott Laboratories. While working for Abbott, she developed expertise in the area of Quality Systems and Regulatory Affairs as a Validation Review Board Member working closely with the FDA developing and optimizing Quality Systems. This background along with her PhD in Biochemistry give Barbara a unique understanding of Cedarburg’s core strengths and an ability to communicate with Clients, Senior Scientists and Plant Personnel.
Back to Top
Mark Millar
Director, Project Management & Resource Coordination
Mark Millar received his BS in Environmental Science from Royal Roads University in Victoria, British Columbia and has previously worked as a Microbiological Laboratory Specialist at Kleen Test Products, a finished product Contract Manufacturer. Mark joined Cedarburg Hauser in 2007 as a QC Analyst and transitioned to his current role as Director of Project Management and Resource Coordination in 2008. In this capacity, Mark is responsible for scheduling and coordinating materials, facilities and personnel to ensure the timely completion of each project.
Back to Top
|
